Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 11, Issue 27, Pages 3501-3509Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161205774414583
Keywords
tumour antigen; immunotherapy; antigen discovery; tolerance
Categories
Ask authors/readers for more resources
During the last decade, a large number of human tumour antigens have been identified. These antigens are classified as tumour-specific shared antigens, tissue-specific differentiation antigens, overexpressed antigens, tumour antigens resulting from mutations, viral antigens and fusion proteins. Antigens recognised by effectors of immune system are potential targets for antigen-specific cancer immunotherapy. However, most tumour antigens are self-proteins and are generally of low immunogenicity and the immune response elicited towards these tumour antigens is not always effective. Strategies to induce and enhance the tumour antigen-specific response are needed. This review will summarise the approaches to discovery of tumour antigens, the current status of tumour antigens, and their potential application to cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available